What to Expect From the Biosimilars Market in 2023
Tuesday, November 8, 2022
3:00 p.m. - 4:00 p.m.
All eyes are on new biosimilars scheduled for market entry in 2023 and 2024. During this session, panelists will discuss the state of the current market, what to watch in 2023 and the factors and challenges likely to influence future biosimilar adoption.
Moderator: Melissa Andel, MPP
Principal, CommonHealth Solutions
Brian Biehn
Director, Biosimilar Commercialization, AmerisourceBergen
Andrew Bourgoin
Principal, Geoffrion Research
Steven Lucio, PharmD, BCPS
Senior Principal, Center for Pharmacy Practice Excellence, Vizient
